<DOC>
	<DOCNO>NCT00215631</DOCNO>
	<brief_summary>Because high incidence post-radiation erectile dysfunction ( ED ) , 72 % external-beam radiotherapy , patient category represent difficult therapeutic challenge . Therefore , prevention ED could effective treatment . Tadalafil , new phosphodiesterase type 5 inhibitor , recently introduce . No study investigate efficacy tadalafil prevent ED patient undergo radiotherapy prostate cancer . Efficacy tadalafil last 36 hour intake . This result prolong continuo enhancement penile vascular responsiveness . This randomized , double-blind , placebo-controlled study design evaluate efficacy 20-mg tadalafil administer 12 month maintain erectile function potent patient undergo external-beam radiotherapy prostate cancer .</brief_summary>
	<brief_title>Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer ?</brief_title>
	<detailed_description>It double-blind , placebo-controlled , randomized trial . Patients schedule external-beam radiotherapy prostate cancer start use tadalafil 20 mg placebo first day radiation . The blinded medication ( active drug placebo ) take every two day start day first radiation 12 month ( 52 week ) radiotherapy . The active drug placebo may take bedtime unrelated sexual activity . In case side effect dose reduce 10 mg. Erectile function assess every 3 month 6 week ( week 58 ) discontinuation drug treatment use question 3 4 International Index Erectile Function ( IIEF ) . Responders ( maintain erectile function ) define combined score &gt; =8 IIEF question 3 4 .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>1 . Men , least 18 year age , willing participate study willing regularly attempt sexual activity . 2 . Patients histologically proven prostate cancer . 3 . Provide sign informed consent . 4 . Patients normal erectile function define combined score &gt; =8 question 3 4 IIEF . 5 . Agree use ED treatment study . 1 . Use treatment ED start study . 2 . History pelvic surgery ( include radical prostatectomy ) 3 . History penile implant 4 . The presence penile deformity make sexual intercourse difficult impossible . 5 . Patients chronic stable angina treat longacting nitrate , patient chronic stable angina require shortacting nitrate last 90 day , angina occur sexual intercourse last 6 month . 6 . Patients unstable angina , history myocardial infarction coronary artery bypass graft surgery percutaneous coronary intervention ( eg , angioplasty stent placement ) within 90 day screen . 7 . Any supraventricular arrhythmia uncontrolled ventricular response ( mean heart rate &gt; 100 bpm ) rest despite medical device therapy , history spontaneous induce sustained ventricular tachycardia ( heart rate &gt; 100 bpm 30 sec ) despite medical device therapy , presence automatic internal cardioverterdefibrillator . 8 . A history sudden cardiac arrest despite medical device therapy . 9 . Any evidence congestive heart failure new , significant conduction defect within 90 day screen . 10 . Systolic blood pressure &gt; 170 &lt; 90 mm Hg diastolic blood pressure &gt; 100 &lt; 50 mm Hg , patient history malignant hypertension . 11 . History significant central nervous system injury ( include stroke spinal cord injury ) within 6 month screen . 12 . History HIV infection . 13 . Any condition would interfere patient 's ability provide inform consent comply study instruction , would place patient increase risk , might confound interpretation study result . 14 . Treatment cancer chemotherapy . 15 . History drug , alcohol , substance abuse within 6 month screen . 16 . Have condition , limitation , disease could , judgment investigator , preclude evaluation response tadalafil .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>erectile dysfunction</keyword>
	<keyword>tadalafil</keyword>
</DOC>